Abstract
This paper reports the experiences of the second clinical trial in the use of isosorbide in the treatment of 34 selected cases of infantile hydrocephalus of all types. Subject to careful biochemical monitoring of serum electrolyte, urea, and acid-base balance, treatment with 2 g/kg body weight 6-hourly is safe. Side effects are immediately eliminated by interrupting therapy. With lower dosage, prolonged maintenance therapy was possible, for as long as 11 months, without side effects and with need for much less frequent biochemical monitoring. Isosorbide effectively prevented the need for shunt therapy in 10 of 34 patients, including 3 infants with uncomplicated congenital hydrocephalus of moderate degree and infants whose hydrocephalus was associated with spina bifida and whose cerebral mantle was between 20 to 25 mm. In posthaemorrhagic and postmeningitic hydrocephalus valuable time was gained before shunt therapy until the infant and his CSF were fit for operation.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- LORBER J. Systematic ventriculographic studies in infants born with meningomyelocele and encephalocele. The incidence and development of hydrocephalus. Arch Dis Child. 1961 Aug;36:381–389. doi: 10.1136/adc.36.188.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lorber J., Bhat U. S. Posthaemorrhagic hydrocephalus. Diagnosis, differential diagnosis, treatment, and long-term results. Arch Dis Child. 1974 Oct;49(10):751–762. doi: 10.1136/adc.49.10.751. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lorber J. Early results of selective treatment of spina bifida cystica. Br Med J. 1973 Oct 27;4(5886):201–204. doi: 10.1136/bmj.4.5886.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lorber J. Isosorbide in the medical treatment of infantile hydrocephalus. J Neurosurg. 1973 Dec;39(6):702–711. doi: 10.3171/jns.1973.39.6.0702. [DOI] [PubMed] [Google Scholar]
- Lorber J. Medical and surgical aspects in the treatment of congenital hydrocephalus. Neuropadiatrie. 1971 Feb;2(3):239–246. doi: 10.1055/s-0028-1091785. [DOI] [PubMed] [Google Scholar]
- Lorber J. Results of treatment of myelomeningocele. An analysis of 524 unselected cases, with special reference to possible selection for treatment. Dev Med Child Neurol. 1971 Jun;13(3):279–303. [PubMed] [Google Scholar]
- Lorber J. Spina bifida cystica. Results of treatment of 270 consecutive cases with criteria for selection for the future. Arch Dis Child. 1972 Dec;47(256):854–873. doi: 10.1136/adc.47.256.854. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lorber J., Zachary R. B. Primary congenital hydrocephalus. Long-term results of controlled therapeutic trial. Arch Dis Child. 1968 Oct;43(231):516–527. doi: 10.1136/adc.43.231.516. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shurtleff D. B., Hayden P. W. The treatment of hydrocephalus with isosorbide, and oral hyperosmotic agent. J Clin Pharmacol New Drugs. 1972 Feb-Mar;12(2):108–114. doi: 10.1002/j.1552-4604.1972.tb00155.x. [DOI] [PubMed] [Google Scholar]
- Shurtleff D. B., Hayden P. W., Weeks R., Laurence K. M. Temporary treatment of hydrocephalus and myelodysplasia with isosorbide: preliminary report. J Pediatr. 1973 Oct;83(4):651–657. doi: 10.1016/s0022-3476(73)80235-5. [DOI] [PubMed] [Google Scholar]